EUVIMEDEUVIMED entdecken
Leitlinie

The APLAR Recommendations for the Management of Psoriatic Arthritis

Ying-Ying Leung iD, Paul Bird, Muhammad Haroon, Mitsumasa Kishimoto, Kichul Shin iD, Ashish Jacob Mathew, Heizel Reyes, Jeffrey Chau, Dennis Neuen, Praveena Chiowchanwisawakit iD, Asal Adnan Ridha iD, Chuanhui Xu und 23 weitere

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70372 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Ying-Ying Leung und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Singapore General Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Psoriatic, Rheumatology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Asia-Pacific League of Associations for Rheumatology, Asia Pacific League of Associations for Rheumatology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Under the auspices of the Asia‐Pacific League of Associations for Rheumatology (APLAR), we aimed to develop broad, evidence‐ and consensus‐based guidelines to aid health professionals managing patients with psoriatic arthritis (PsA) in the region.

Methods

A working group of 35 members comprising rheumatologists, dermatologists, and patient research partners from 18 APLAR countries was convened. The working group conducted systematic literature reviews to derive the quality of evidence via GRADE methods in supporting the efficacy and safety of classes of therapeutic agents for the management of active PsA , its comorbidities, and screening for specific infection concerns in the region. Recommendation statements on the principles of management and the best use of therapeutic drugs were developed. Consensus within the working group was achieved. An external voting panel, five from each of the 18 APLAR countries, was convened to confirm further agreement on the recommendation statements.

Results

The main literature review included 178 articles from clinical trials for PsA. Additional articles on the evidence for managing comorbidities, uveitis, inflammatory bowel disease, and screening for chronic hepatitis B and latent tuberculosis were reviewed. The working group discussed and reached consensus on eight management principles and 16 recommendation statements for managing PsA. Endorsement from an external voting panel ( n = 90, response rate 80%) was achieved.

Conclusion

These first recommendations for the management of PsA patients in the APLAR regions were developed based on the best available evidence and region‐specific considerations through discussion among rheumatologists, dermatologists, and patients, with strong agreement from an external expert panel.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antirheumatic AgentsArthritis, PsoriaticRheumatologyHumansComorbidityConsensusEvidence-Based MedicineTreatment OutcomeSystematic Reviews as Topic

Stichwörter der Autor:innen

psoriatic arthritisquality of evidencetreatment recommendation

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Department of Rheumatology, Singapore General Hospital, Singapore, Singapore.
  • Duke-NUS Medical School, Singapore, Singapore.
  • University of New South Wales, Sydney, New South Wales, Australia.
  • Fatima Memorial Hospital, and FMH College of Medicine and Dentistry, Lahore, Pakistan.
  • Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Division of Rheumatology, College of Medicine, Seoul National University, Seoul, Korea.

ORCID-Profile: Ying-Ying Leung, Kichul Shin, Praveena Chiowchanwisawakit, Asal Adnan Ridha, Fariz Yahya, Ho So, Sho Fukui, Soosan G Soroosh, Akimichi Morita, Perdana Aditya Rahman, Avanish Jha, Lai-Shan Tam

Förderung

  • Asia-Pacific League of Associations for Rheumatology
  • Asia Pacific League of Associations for Rheumatology

Zitieren

APA

Leung, Y. Y., Bird, P., Haroon, M., Kishimoto, M., Shin, K., Mathew, A. J., Reyes, H., Chau, J., Neuen, D., Chiowchanwisawakit, P., Ridha, A. A., Xu, C., Taylor, W., Yahya, F., So, H., Fukui, S., Van Hung, N., Soroosh, S. G., Wahono, C. S., …, & Tam, L. S. (2025). The APLAR Recommendations for the Management of Psoriatic Arthritis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70372

Vancouver

Leung YY, Bird P, Haroon M, Kishimoto M, Shin K, Mathew AJ, et al. The APLAR Recommendations for the Management of Psoriatic Arthritis. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70372

BibTeX
@article{Leung2025,
  author = {Leung, Ying-Ying and Bird, Paul and Haroon, Muhammad and Kishimoto, Mitsumasa and Shin, Kichul and Mathew, Ashish Jacob and Reyes, Heizel and Chau, Jeffrey and Neuen, Dennis and Chiowchanwisawakit, Praveena and Ridha, Asal Adnan and Xu, Chuanhui and Taylor, William and Yahya, Fariz and So, Ho and Fukui, Sho and Van Hung, Nguyen and Soroosh, Soosan G and Wahono, Cesarius Singgih and Pok, Lydia Say Lee and Gonzales, Juan Raphael and Yeo, Yi Wei and Dandeniya, Chathurika and Morita, Akimichi and Rahman, Perdana Aditya and Basim, Shahlaa and Deshapriya, Kalum and Satti, Eman and Phong, Nguyen Duc and Kim, Min Jung and Jha, Avanish and Cackamvalli, Priyanka Moovara and Rafique, Ahmed and Islam, Md Nazrul and Tam, Lai-Shan},
  title = {The APLAR Recommendations for the Management of Psoriatic Arthritis},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70372}
}
Kostenlos starten →